Delivery Order SPE2DB22D1106-SPE2DB25FDMU2

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,872.04 firm fixed-price delivery order is for the supply of febuxostat 80 mg tablets, a medication used to treat gout. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,559.71 firm fixed-price delivery order is for the supply of febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of March 20, 2024 and was awarded on March 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FEBUXOSTAT 40 MG TABLET 30S, a medication used to treat gout. The contract has a ceiling value of $1,064.58 and is a Firm Fixed Price Delivery Order with a completion date of May 14, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,388.40 firm fixed-price delivery order is for the supply of Febuxostat 40 mg tablets, a medication used to treat gout. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of febuxostat 40 mg tablets, a medication used for the treatment of gout. The delivery order has a ceiling value of $3,060.37 and is a Firm Fixed Price contract. The period of performance runs through December 19, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,391.75 Firm Fixed Price Delivery Order contract is for the supply of 40 mg Febuxostat tablets. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,558,119,086 units of Febuxostat 40 mg tablets. The $2,347.52 firm fixed-price contract has an ultimate completion date of August 17, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of...
This federal contract award is for the delivery of febuxostat 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 17, 2025, with a completion date of March 18, 2025. The contract has a ceiling value of $1,245.38 and is a firm fixed-price delivery order. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,481.02 firm fixed-price delivery order is for the supply of febuxostat 80 mg tablets, a medication used to treat gout. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,633.92, is a delivery order contract with a firm fixed price for the supply of febuxostat 40 mg tablets. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDMU2
    Delivery Order

This federal contract award, valued at $2,317.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Febuxostat 40 mg tablets, a medication used to treat gout.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/20/25, 1:58 PM